## Abstract The effects of Osteogenic Protein‐1 (OP‐1, BMP‐7) on the differentiation of the pluripotent mesenchymal cell line, C2C12, were examined. OP‐1 at 50 ng/ml partially inhibited myotube formation in C2C12 cells, while OP‐1 at 200 ng/ml completely inhibited myotube formation and induced the
Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells
✍ Scribed by Lee-Chuan C. Yeh; Alicia D. Tsai; Michelle C. Zavala; John C. Lee
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 253 KB
- Volume
- 201
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Previous studies have shown that osteogenic protein‐1 (OP‐1; also known as BMP‐7) induces differentiation of the pluripotent mesenchymal cell line C2C12 into osteoblastic cells. OP‐1 also alters the steady‐state levels of messenger RNA (mRNA) encoding for the cartilage‐derived morphogenetic proteins (CDMPs) in C2C12 cells. In the present study, the effects of exogenous CDMPs on bone cell differentiation induced by OP‐1 in C2C12 cells were examined. Exogenous CDMP‐1, ‐2, and ‐3 synergistically and dose‐dependently enhanced OP‐1 action in stimulating alkaline phosphatase (AP) activity and osteocalcin (OC) mRNA expression. AP staining studies revealed that the combination of OP‐1 and CDMP enhanced OP‐1 action by stimulating those cells that had responded to OP‐1 and not by activating additional cells. The combination did not change the mRNA expression of the BMPs and their receptors. CDMP‐1 enhanced the suppression of the OP‐1‐induced expression of the myogeneic differentiation regulator MyoD. CDMP‐1 and OP‐1 alone stimulated Smad5 protein expression, but the combination of OP‐1 and CDMP‐1 stimulated synergistically Smad5 protein expression. Thus, one mechanism of the observed synergy involved enhancement of the induced Smad5 protein expression. At the same protein concentration, CDMP‐1 is most potent in enhancing OP‐1 activity in inducing osteoblastic cell differentiation of C2C12 cells. CDMP‐3 is about 80% as potent as CDMP‐1, and CDMP‐2 is the least potent (about 50% of CDMP‐1). © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract In the present study, we examined the hypothesis that the C‐type natriuretic peptide (CNP) enhances osteogenic protein‐1 (OP‐1) action in stimulating osteoblastic cell differentiation in primary cultures of fetal rat calvaria cell (FRC). CNP enhanced synergistically the OP‐1‐induced Alk
During embryonic development, cartilage formation involves the condensation of mesenchymal stem cells and a series of maturation steps that ultimately results in the mineralized hypertrophic chondrocyte. The embryonic, murine, mesenchymal stem cell line, C3H/10T1/2, is pluripotent; exposure to azacy
The bone morphogenetic protein (BMP)-2 is a potent osteoinductive signal, inducing bone formation in vivo and osteoblast differentiation from non-osseous cells in vitro. The runt domain-related protein Cbfa1/PEBP2␣A/ AML-3 is a critical component of bone formation in vivo and transcriptional regulat
Recently, a variant of insulin-like growth factor-1, mechano-growth factor (MGF), has been discovered whose 24-amino-acid carboxy end is protective in models of stroke, nerve injury, and amyotrophic lateral sclerosis, suggesting broad-spectrum neuroprotective properties. Moreover, we recently demons